Sleep apnea and atrial fibrillation; 2012 update

Current Cardiology Reviews

Volumn 8, Issue 4, 2012, Pages 265-272

  Digby, Genevieve C ^a   Baranchuk, Adrian ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Atrial fibrillation; Obstructive sleep apnea; Sleep apnea

Indexed keywords

DISEASE ASSOCIATION; DISEASE SEVERITY; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SLEEP DISORDERED BREATHING; THORAX PRESSURE; TRACHEOSTOMY;

ATRIAL FIBRILLATION; AUTONOMIC NERVOUS SYSTEM DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INFLAMMATION; PRESSURE; RECURRENCE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84870193923     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/157340312803760811     Document Type: Review

References (84)

1. Fuster V, Ryden LE, Connom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (writing committee to revise the 2001 guidelines for management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-354.
2. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham heart study. Circulation 2004; 110: 1042-6.
3. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001; 18: 2370-5.
4. Falk RH. Atrial fibrillation. N Engl J Med 2001; 344: 1067.
5. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation 1998; 98:946-52.
6. Baranchuk A, Simpson CS, Redfearn DP, et al. It's time to wake up! Sleep apnea and cardiac arrhythmias. Europace 2008; 6: 666-667.
7. Todd K, McIntyre WF, Baranchuk A. Obstructive sleep apnea and atrial fibrillation: a review of the literature. Nat Sci Sleep 2010; 2: 1-7.
8. Young T, Peppard PE, Gottleib DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-39.
9. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2004; 291(5): 557.
10. Mansfield DR, Naughton MT. Obstructive Sleep Apnoea, Congestive Heart Failure and Cardiovascular Disease. Heart Lung Circ 2005; 14(S): S2-7.
11. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004; 291:2013-6.
12. Lavie P, Herer P, Peled R, et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995;18:149-57.
13. Weiss JW, Launois SH, Anand A, et al. Cardiovascular morbidity in obstructive sleep apnea. Prog Cardiovasc Dis 1999; 41: 367-76.
14. Nieto FJ, Young TB, Lind BK, et al. Association of sleepdisordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283: 1829-36.
15. Roux F, D'Ambrosio C, Mohsenin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med 2000; 108: 396-402.
16. Rao A, Georgiadou P, Francis DP, et al. Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms. J Sleep Res 2006; 15: 81-8.
17. Yazdan-Ashoori P, Baranchuk A. Obstructive sleep apnea may increase the risk of stroke in AF patients: refining the CHADS2 score. Int J Cardiol 2011; 246(2): 131-3.
18. Rechtschaffen A, Kales A. A manual of standarized terminology, techniques and scoring system for sleep stages of human subjects. Washington, D.C., US Government Printing Office. US Public Health Service. (NIH 1968; publication No. 204).
19. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667-89.
20. Gami AS, Friedman PA, Chung MK, et al. Therapy insight: interactions between atrial fibrillation and obstructive sleep apnea. Nat Clin Pract Cardiovasc Med 2005; 2: 145-9.
21. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52: 490-4.
22. Hoffstein V, Mateika S. Cardiac arrhythmias, snoring, and sleep apnea. Chest 1994; 106: 466-71.
23. Valencia-Flores M, Orea A, Castano VA, et al. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. Obes Res 2000; 8: 262-9.
24. Caples SM, Somers VK. Sleep-disordered breathing and atrial fibrillation. Prog Cardiovasc Dis 2009; 51: 411-5.
25. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the sleep heart health study. Am J Respir Crit Care Med 2006; 173: 910-6.
26. Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007; 49: 565-71.
27. Flemons WW, Remmers JE, Gillis AM. Sleep apnea and cardiac arrhythmias. Is there a relationship? Am Rev Respir Dis 1993; 148: 618-21.
28. Porthan KM, Melin JH, Kupila JT, et al. Prevalence of sleep apnea syndrome in lone atrial fibrillation: a case-control study. Chest 2004; 125: 879-85.
29. Tanigawa T, Yanagishi K, Sakurai S, et al. Arterial oxygen desaturation during sleep and atrial fibrillation. Heart 2006; 92: 1854-5.
30. Mooe T, Gullsby S, Rabben T, et al. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary bypass surgery. Coron Artery Dis 1996; 7: 475-8.
31. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003; 107: 2589-94.
32. Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110: 364-7.
33. Ng C, Liu T, Shehata M, et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol 2011; 108: 47-51.
34. Bitter T, Nölker G, Vogt J, et al. Predictors of recurrence in patients undergoing cryoballoon ablation for treatment of atrial fibrillation: The independent role of sleep-disordered breathing. J Cardiovasc Electrophysiol 2012; 23(1): 18-25.
35. van Oosten EM, Furqan MA, Redfearn DP, et al. Sleep apnea does not predict atrial flutter recurrence after atrial flutter ablation. J Interv Card Electrophysiol 2011.
36. Baranchuk A, Parfrey B, Lim L, et al. Interatrial block in patients with obstructive sleep apnea. Cardiol J 2011; 18(2): 171-5.
37. Allessie M, Ausma J, Schotten U. Electrical, contractile, and structural remodeling during atrial fibrillation. Cardiovasc Res 2002; 54: 230-46.
38. Ariyarajah V, Spodick DH. The Bachmann bundle and interatrial conduction. Cardiol Rev 2006; 14: 194-9.
39. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998; 97: 2154-9.
40. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160: 1101-6.
41. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. Circulation 2008; 118: 1080-111.
42. Jais P, Haissaguerre M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95: 572-6.
43. Linz D, Schotten U, Neuberger HR, et al. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm 2011; 8(9): 1436-43.
44. Aydin M, Altin R, Ozeren A, et al. Cardiac autonomic activity in obstructive sleep apnea. Tex Heart Inst J 2004; 31: 132-6.
45. Narkiewicz K, Montano N, Cogliati C, et al. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98: 1071-7.
46. Somers VK, Mark AL, Zavala DC, et al. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989; 67: 2101-6.
47. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-904.
48. Seaborn GEJ, Pang, H, Redfearn DP, et al. Autonomic profile of patients referred to a sleep disorder clinic: impact of CPAP on the autonomic nervous system. Europace 2012 (Abstract) (in press).
49. Awan K, Baranchuk A, Guzik P, et al. The microstructure of heart rate asymmetry during sleep in relation to the severity of obstructive sleep apnea syndrome. Cardiol J 2011(Abstract); 18(5): 588.
50. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
51. Kannel WB, Wolf PA, Benjamin EJ. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: populationbased estimates. Am J Cardiol 1998; 82: 2N-9N.
52. Chugh SS, Blackshear JL, Shen WK, et al. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001; 37: 371-8.
53. Pritchett AM, Mahoney DW, Jacobsen SJ, et al. Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 2005; 45: 87-92.
54. Tsang TS, Gersh BJ, Appleton CP, et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 2002; 40: 1636-44.
55. Fung JW, Li TS, Choy DK, et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 2002; 121: 422-9.
56. Kraiczi H, Caidahl K, Samuelsson A, et al. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 2001; 119: 1085-91.
57. Alchanatis M, Paradellis G, Pini H, et al. Left ventricular function in patients with obstructive sleep apnea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration 2000; 67: 367-71.
58. Dimitri H, Ng M, Brooks AG. Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation. Heart Rhythm 2011; (in press).
59. Hatipoglu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 2003; 70: 665-71.
60. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated Creactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462-4.
61. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-91.
62. Jo JPL, Lourenco P, Azevedo A, et al. Prognostic value of highsensitivity C-reactive protein in heart failure: a systematic review. J Cardiac Fail 2009; 15: 256-66.
63. Tilkian AC, Guilleminault C, Schroeder JS, et al. Sleep-induced apnea syndrome: prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977; 63: 348-58.
64. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365(9464): 1046-53.
65. Doherty LS, Kiely JL, Swan V, et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005; 127(6): 2076-84.
66. Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled Trial of Continuous Positive Airway Pressure in Obstructive Sleep Apnea and Heart Failure. Am J Resp Crit Care 2004; 169(3): 361-6.
67. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348(13): 1233-41.
68. Bradley TD, Hall MJ, Ando S-I, et al. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest 2001; 119(6): 1827-35.
69. Shivalkar B, Van de Heyning C, Kerremans M, et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 2006;47(7):1433-9.
70. Dursunoglu N, Dursunoglu D, Ozkurt S, et al. Effects of CPAP on left ventricular structure and myocardial performance index in male patients with obstructive sleep apnoea. Sleep Med 2007; 8(1): 51-9.
71. Johnson CB, Beanlands RS, Yoshinaga K, et al. Acute and chronic effects of continuous positive airway pressure therapy on left ventricular systolic and diastolic function in patients with obstructive sleep apnea and congestive heart failure. Can J Cardiol 2008; 24(9): 697-704.
72. Liston R, Deegan PC, McCreery C, et al. Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J 1995; 8: 430-5.
73. Digby GC, Driver HS, Fitzpatrick M, et al. Use of bioimpedance to assess changes in hemodynamics during acute administration of CPAP. Cardiol Res 2011; 2(2): 51-7.
74. Bradley TD, Holloway RM, McLauglin PR, et al. Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis 1992; 145: 377-82.
75. Davies RJ, Jarrington KJ, Ormerod OJ, et al. Nasal continuous positive airway pressure in chronic heart failure with sleepdisordered breathing. Am Rev Respir Dis 1993; 147: 630-4.
76. Pinsky, MR. Sleep with the enemy: the heart in obstructive sleep apnea. Chest 2002; 121(4): 1022-4.
77. Gami AS, Friedman PA, Chung MK, et al. Therapy insight: interactions between atrial fibrillation and obstructive sleep apnea. Nat Clin Pract Cardiovasc Med 2005; 2: 145-9.
78. Abe H, Takahashi M, Yaegashi H. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels. 2010; 25: 63-9.
79. Patel D, Mohanty P, Di Biase L, et al. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: The impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol 2010; 3(5): 445-51.
80. Pang H, Redfearn DP, Simpson CS et al. Reverse atrial electrical remodeling induced by CPAP in patients with severe obstructive sleep apnea. Europace, 2011; P673: 87 (abstract).
81. Pang H, Ronderos R, Pérez-Riera AR, et al. Reverse electrical remodelling: a systematic review. Cardiol J 2011; 18(6): 625-31.
82. Oliveira W, Campos O, Cintra F, et al. Impact of continuous positive airway pressure treatment on left atrial volume and function in patients with obstructive sleep apnoea assessed by real-time threedimensional echocardiography. Heart 2009; 95: 1872-8.
83. Khan A, Latif F, Hawkins B, et al. Effects of obstructive sleep apnea treatment on left atrial volume and left atrial volume index. Sleep Breath 2008; 12: 141-7.
84. Baranchuk A. Sleep Apnea, Cardiac Arrhythmias and Conduction Disorders. J Electrocardiol 2012 (Epub ahead of print).